#Product Trends
JC200 by Chongqing Haifu - Focused ultrasound tumor therapeutic system
Benign:
•uterine fibroids and adenomyosis
Malignant:
• liver tumors
• kidney tumors
• breast tumors
• bone tumors
• pancreas tumors
Contraindications:
• Tumor of head
• Tumor in spine and vertebral canal
• Tumor of gastrointestinal tract
• Tumor in thoracic cavity
• Tumor of hollow viscous with obstruction
Clinical Advangtages:
• Noninvasive treatment to preserve organs and structures, with no blood transfusion and no radiation
• Conformal and precise ablation
• One time treatment, no limitation by tumor size and shape
• Real-time ultrasound-guided therapy with digital quantitative analysis
• Activation of immune system
Approvals: Europe: CE, China: CFDA